|
Canada-0-FreightForwarding شركة الأدلة
|
شركة أخبار :
- What is Lipoprotein (a) and How Does It Impact My Heart Health?
In the following years, she researched Lp (a), talked to health care professionals and started a foundation to raise awareness of the condition Tremulis noted that her work led to the Centers for Disease Control and Prevention (CDC) recognizing high Lp (a) levels as a clinical diagnosis in 2018
- Association Between Lipoprotein(a) Testing, Lipid‐Lowering Therapy . . .
Lipoprotein (a) (Lp [a]) can refine atherosclerotic cardiovascular disease risk assessment and guide lipid‐lowering therapy intensification (LLTI) However, the association between Lp (a) testing and LLTI across large health systems is not well characterized
- About Lipoprotein (a) | Heart Disease, Family Health History, and . . .
If you have high levels of lipoprotein (a) (Lp (a)), you are more likely to have a heart attack, a stroke, or aortic stenosis, especially if you have familial hypercholesterolemia or signs of coronary heart disease
- Lipoprotein(a) as a Causal Risk Factor for Cardiovascular Disease
There are emerging data on the association between Lp (a) and ischemic stroke, peripheral arterial disease, and heart failure; however, the associations are not as strong Several lines of evidence support Lp (a) as a causal risk factor for ASCVD and CAVS
- Addressing the Lp (a) hypothesis: will lowering Lp (a) decrease the . . .
Other Lp (a)-lowering therapies that are being assessed in cardiovascular outcomes trials include the siRNA lepodisiran and the small molecule muvalaplin, the latter of which reduces Lp (a) levels
- Feature | Lipoprotein(a): An Independent Risk Factor For CV Disease
The 2024 focused update from the National Lipid Association recommends measurement of Lp (a) levels at least once in every adult, with individuals having Lp (a) levels ≥50 mg dL considered high risk
- PATIENT-CENTERED EDUCATION FROM THE NATIONAL LIPID ASSOCIATION Elevated . . .
» Lp(a) can cause plaque to build up in the walls of the blood vessels This can lead to a decrease in blood flow to many organs including the heart, brain, legs, and other parts of the body and result in heart attacks and or strokes
- Lipoprotein (a): An update on testing and treatment
However, researchers are working to better understand changes that may occur in Lp (a) in women around the time of menopause and for men and women with certain medical conditions
- Lipoprotein (a) – From Biomarker to Therapy: A Review for the Clinician
Lp (a) is a lipoprotein variant similar to LDL but includes apolipoprotein (a), which influences its pathogenic potential Elevated Lp (a) levels are genetically determined and have been implicated in promoting vascular inflammation, atherogenesis, enhanced calcification, and thrombosis
- Lipoprotein (a) | Cardiology - JAMA Network
This JAMA Insights discusses lipoprotein (a), including factors associated with elevated lipoprotein (a) levels, how to manage them, and atherosclerotic
|
|